MedTrace Logo

Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.

NCT01541813 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2015-03-10

No results posted yet for this study

Summary

Chronic iron overload is responsible for morbidity and mortality. There are many genetic and acquired causes. One of them is an hepcidin deficiency. Hepcidin is the regulating hormone for iron. The study explores this specific cause, and aim to characterize this iron overload in term of clinical, biological, genetic and functional specificities.

Conditions

  • Rare Iron Overloads Except C282Y Homozygosity

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Edouard Bardou-Jacquet, MD · CHU Rennes

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2014-08-31
Completion
2014-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01541813 on ClinicalTrials.gov